ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about their cancer journeys.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

For patients with extensive-stage small cell lung cancer, Loqtorzi was shown to improve progression-free survival and overall survival.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Treatment with subcutaneous Keytruda plus berahyaluronidase alfa meets phase 3 trial end points in the treatment of metastatic non–small cell lung cancer.

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of radiotherapy to TKI treatment.